# Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058)

> **NCT00090298** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 2815 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** MK0653A, ezetimibe (+) simvastatin
- **DRUG:** Comparator: Rosuvastatin

## Key facts

- **NCT ID:** NCT00090298
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2004-12
- **Final completion:** 2004-12
- **Target enrollment:** 2815 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00090298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00090298, "Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00090298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*